e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
COPD - pathogenesis I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort
S. Bozinovski, A. Hutchinson, D. Smallwood, M. Thompson, J. Black, L. Irving, G. Anderson (Parkville, Australia)
Source:
Annual Congress 2005 - COPD - pathogenesis I
Session:
COPD - pathogenesis I
Session type:
Thematic Poster Session
Number:
439
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Bozinovski, A. Hutchinson, D. Smallwood, M. Thompson, J. Black, L. Irving, G. Anderson (Parkville, Australia). Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort. Eur Respir J 2005; 26: Suppl. 49, 439
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Time course of systemic inflammatory markers during acute exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013
Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Markers of severity and inflammatory profile during exacerbations of severe asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Determinants of heightened systemic inflammation at exacerbation of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 115s
Year: 2006
Infectious exacerbations of COPD: IL-18 and its relation to markers of inflammation
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept